Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04821141 |
Recruitment Status :
Recruiting
First Posted : March 29, 2021
Last Update Posted : February 6, 2023
|
Sponsor:
University of Kansas Medical Center
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Carol Fabian, MD, University of Kansas Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | August 1, 2025 |
Estimated Study Completion Date : | January 31, 2026 |